Sohag Faculty of Medicine
Sohag, Sohag Governorate, 82511, Egypt
Location status: Recruiting
NCT Number: NCT07346560
Patients with uncomplicated rhegmatogenous retinal detachment will be recruited. All eyes will underwent 23G PPV with silicon oil tamponade. The eyes will be classified into two groups according to the timing of ILM peeling. Group A, ILM peelin will be performed during the first intervention, while in group B, it will be done at the time of silicon oil extraction.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Sohag, Sohag Governorate, 82511, Egypt
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ILM peeling during the 1st surgical intervention for rRD
ILM peeling is delayed for the time of silicon oil extraction
Time frame: From enrollment till 3 months postoperative
Contact information is provided by the study sponsor or research team.
Sohag University
Other
Primary Versus Secondary Internal Limiting Membrane Peeling in Uncomplicated Retinal Detachment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07495319
Eye Diseases, Retina Disorder
Karachi, Pakistan
View Trial DetailsNCT07034469
Eye Diseases, Retinal Detachment
View Trial DetailsNCT07386678
Eye Diseases, Proliferative Vitreoretinopathy
London, United Kingdom
View Trial DetailsNCT05620901
Cardiovascular Diseases, Coats' Disease
Durham, North Carolina, United States
View Trial Details